Millennium Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,115
| Closed | -$9K | – | 5546 |
|
|
2022
Q3 | $9K | Buy |
+1,115
| New | +$9K | ﹤0.01% | 5043 |
|
|
2022
Q2 | – | Sell |
-869
| Closed | -$33K | – | 5915 |
|
|
2022
Q1 | $33K | Sell |
869
-494
| -36% | -$18.8K | ﹤0.01% | 5004 |
|
|
2021
Q4 | $77K | Sell |
1,363
-47
| -3% | -$2.66K | ﹤0.01% | 4924 |
|
|
2021
Q3 | $102K | Sell |
1,410
-7,291
| -84% | -$527K | ﹤0.01% | 4919 |
|
|
2021
Q2 | $834K | Buy |
8,701
+6,388
| +276% | +$612K | ﹤0.01% | 3838 |
|
|
2021
Q1 | $342K | Buy |
2,313
+1,328
| +135% | +$196K | ﹤0.01% | 3866 |
|
|
2020
Q4 | $138K | Buy |
+985
| New | +$138K | ﹤0.01% | 3856 |
|
|
2020
Q3 | – | Sell |
-20,966
| Closed | -$3.68M | – | 3975 |
|
|
2020
Q2 | $3.68M | Buy |
20,966
+19,794
| +1,689% | +$3.48M | 0.01% | 1626 |
|
|
2020
Q1 | $167K | Sell |
1,172
-261
| -18% | -$37.2K | ﹤0.01% | 2778 |
|
|
2019
Q4 | $206K | Buy |
+1,433
| New | +$206K | ﹤0.01% | 3151 |
|
|
2017
Q3 | – | Sell |
-44
| Closed | -$11K | – | 3603 |
|
|
2017
Q2 | $11K | Buy |
+44
| New | +$11K | ﹤0.01% | 3154 |
|
|
2016
Q2 | – | Sell |
-25
| Closed | -$33K | – | 3358 |
|
|
2016
Q1 | $33K | Buy |
+25
| New | +$33K | ﹤0.01% | 2932 |
|
|
2015
Q4 | – | Sell |
-60
| Closed | -$66K | – | 3564 |
|
|
2015
Q3 | $66K | Sell |
60
-204
| -77% | -$224K | ﹤0.01% | 3108 |
|
|
2015
Q2 | $265K | Sell |
264
-3
| -1% | -$3.01K | ﹤0.01% | 2734 |
|
|
2015
Q1 | $272K | Sell |
267
-1,802
| -87% | -$1.84M | ﹤0.01% | 2722 |
|
|
2014
Q4 | $6.9M | Sell |
2,069
-143
| -6% | -$477K | 0.01% | 1116 |
|
|
2014
Q3 | $6.41M | Sell |
2,212
-408
| -16% | -$1.18M | 0.02% | 1051 |
|
|
2014
Q2 | $9.97M | Buy |
2,620
+370
| +16% | +$1.41M | 0.03% | 763 |
|
|
2014
Q1 | $12.2M | Buy |
+2,250
| New | +$12.2M | 0.04% | 605 |
|